Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 12, 2018

SELL
$100.43 - $118.09 $261,118 - $307,034
-2,600 Closed
0 $0
Q3 2017

Nov 06, 2017

BUY
$96.72 - $109.26 $251,472 - $284,076
2,600
2,600 $281,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.47B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Zweig Di Menna Associates LLC Portfolio

Follow Zweig Di Menna Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zweig Di Menna Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zweig Di Menna Associates LLC with notifications on news.